Albert Labs International Corp. (CSE: ABRT)

Canada flag Canada · Delayed Price · Currency is CAD
0.0050
0.00 (0.00%)
Jul 15, 2024, 8:38 AM EST
-85.71%
Market Cap 372.07K
Revenue (ttm) n/a
Net Income (ttm) -2.31M
Shares Out 74.41M
EPS (ttm) -0.04
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Open n/a
Previous Close 0.0050
Day's Range 0.0050 - 0.0050
52-Week Range 0.0050 - 0.0350
Beta 3.13
Analysts n/a
Price Target n/a
Earnings Date Nov 29, 2024

About Albert Labs International

Albert Labs International Corp., a biopharmaceutical drug discovery company, researches and develops drugs for psychedelic-assisted therapy for patients with urgent and unmet needs in Canada and the United Kingdom. It develops KRN-101, is a solution for cancer-related anxiety. The company is based in Burnaby, Canada. [Read more]

Industry Biotechnology
Sector Healthcare
CEO Navchand Jagpal
Country Canada
Stock Exchange Canadian Securities Exchange
Ticker Symbol ABRT
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.